THIS CONTENT IS FOR SCIENTIFIC AND EDUCATIONAL PURPOSES - NOT FOR SALES OR PROMOTIONAL USAGE
Memorial Sloan Kettering (MSK) approach to ablative radiotherapy
Dr. Christopher Crane and Dr. Neelam Tyagi from Memorial Sloan Kettering, USA, discuss how MSK moved from treating locally advanced pancreatic patients with ablative doses on conventional linacs to treating them using MR-guided RT (MRgRT) in just 5 fractions. They also present the protocol parameters for their clinical approach and the clinical outcomes of pancreatic patients treated with an ablative dose on the MR-Linac.